Interventional Clinical Trial
— DiExOfficial title:
In Vivo and in Vitro Anabolic Potential of Essential Amino Acids Following Resistance Exercise
Verified date | November 2023 |
Source | University of Toronto |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study seeks to investigate the anabolic potential of a dileucine-enriched essential amino acid (EAA) formulation compared with a branched chain amino acid (BCAA) alternative and a collagen beverage on muscle protein anabolism and catabolism following a bout of resistance exercise training. To do this, investigators will employ a novel 'breath test' method developed in our laboratory as well as blood and urine sampling. The results of this study will allow us to better understand the anabolic potential of dileucine which could have implications for people engaging in regular resistance training (such as athletes) as well as people that need to preserve muscle mass (older people who are susceptible to anabolic resistance and sarcopenia, or muscle wasting).
Status | Active, not recruiting |
Enrollment | 12 |
Est. completion date | January 30, 2024 |
Est. primary completion date | July 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Trained individuals currently performing structured exercise (e.g., running, weightlifting, team-sport activity) at least 2 days per week for the previous 3 months Exclusion Criteria: - Inability to perform physical activity as determined by the PAR-Q - Inability to adhere to protocol guidelines (e.g., alcohol, habitual diet) - Regular tobacco use - Illicit drug use (e.g., growth hormone, testosterone, etc.) - Diagnosed medical condition under the care of a physician (e.g. type 2 diabetes) - Inability to abstain from supplements (e.g. protein, creatine, HMB, BCAA, phosphatidic acid, etc.) at least three weeks before the trial - Individuals on any medications known to affect protein metabolism (e.g., corticosteroids, non-steroidal anti-inflammatories, or prescription-strength acne medications) - Participants that are amenorrheic (females only) - On medications that may interfere with protein metabolism (e.g. anti-inflammatory drugs, hormone therapy) - Regular tobacco use (e.g. daily use of oral or inhaled tobacco) - Illicit drug use (e.g. growth hormone, testosterone, etc.) - Inability to comply with the study protocol as judged by the investigators |
Country | Name | City | State |
---|---|---|---|
Canada | Goldring Centre for High Performance Sport at the University of Toronto | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
University of Toronto |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Whole-Body Protein Synthesis | Investigators will measure the enrichment of [13CO2] in the breath by isotope ratio mass spectrometry (IRMS) in atom percent excess (APE). The measurement of carbon dioxide production (VCO2) and stable isotope tracer enrichment in the breath allows for the assessment of the rate at which amino acids are used for energy (i.e., oxidized), rather than for protein synthesis (i.e., retained in the body) by calculating the fraction of expired CO2 that contains 13C. Leucine retention (umol/kg) will then be calculated from the difference between the known amount of leucine provided (ingested) and leucine oxidation (as determined from 13CO2 breath enrichment). | 6 hours | |
Secondary | Urinary Measures (Muscle Protein Breakdown) | Investigators will measure urinary 3-methylhistidine (3MH) as an indirect marker of muscle protein breakdown over the course of the trial (6 hours) through pooled urine collection vs baseline urine. | 6 hours | |
Secondary | Murine Cell-Based Experiments (ex-vivo experiments) -hypertrophy | Investigators will use human serum obtained from fasted and fed timepoints (15, 30, 45 and 60 minutes following beverage consumption) to condition cell culture media (20% volume). To determine the effects of using fasted and/or fed 'human-conditioned' culture media on cell growth, myotube diameter (hypertrophy) will be measured via microscopy following short term (4 hours) and long-term (24 hour) incubation in the human conditioned culture media. | 60 minutes | |
Secondary | Murine Cell-Based Experiments (ex-vivo experiments) - Protein Synthesis | Investigators will use human serum obtained from fasted and fed timepoints (15, 30, 45 and 60 minutes following beverage consumption) to condition cell culture media (20% volume). To determine the effects of using fasted and/or fed 'human-conditioned' culture media on cell protein synthesis, puromycin incorporation (measure of protein synthesis) will be measured via western blot. | 60 minutes | |
Secondary | Murine Cell-Based Experiments (ex-vivo experiments) - mTORC1 Signalling | Investigators will use human serum obtained from fasted and fed timepoints (15, 30, 45 and 60 minutes following beverage consumption) to condition cell culture media (20% volume). To determine the effects of using fasted and/or fed 'human-conditioned' culture media on cell anabolic signalling mTORC1 signalling will be measured via western blot. | 60 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05336708 -
The Effect of Acupressure on Fatigue
|
N/A | |
Recruiting |
NCT06054620 -
The Effect of Exercise and Presleep Nutrition on Muscle Connective Tissue Remodelling
|
N/A | |
Recruiting |
NCT05060484 -
A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years
|
Phase 2 | |
Active, not recruiting |
NCT05554653 -
Influence of Leucine Enriched Amino Acids on Myofibrillar and Collagen Protein Synthesis
|
N/A | |
Completed |
NCT03756935 -
Early Detection of Intra Operative Hypotension (IOH) During the Induction of General Anaesthesia
|
||
Recruiting |
NCT05145712 -
Quantitative Bowel Readiness Assessment System in Predicting the Missed Detection Rate of Adenomas
|
N/A | |
Not yet recruiting |
NCT06468046 -
Mama Empoderada: Adapting a Novel Mental Health Prevention Intervention for Migrant Mothers With Young Children
|
N/A | |
Completed |
NCT03853226 -
Rational for the Use of Velocity-Pressure Loop in the Operating Room
|
||
Recruiting |
NCT03921164 -
Non Invasive Use of Pressure-Volume Loop in the Operating Room
|
||
Completed |
NCT03876379 -
Brain Power Spectral Density Under Propofol
|
||
Recruiting |
NCT02778724 -
France PCI Registry : National Observatory of Interventional Cardiology
|
||
Terminated |
NCT03585855 -
Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)
|
N/A | |
Completed |
NCT03769142 -
Cerebral Perfusion During Induction of General Anesthesia
|